I founded Innovare Genetics and built its end-to-end genomic interpretation platform, carrying WGS, exome, panel, and microarray data from FASTQ to signed clinical reports.
I develop auditable ACMG classification, CYP2D6 pharmacogenomics, ancestry-calibrated polygenic risk scoring, and NLP-driven variant prioritisation. My AI scoring layer reduces hundreds of thousands of variants to a reviewable shortlist while keeping evidence and uncertainty visible.
Across seven years in genetics, NGS, and applied machine learning, I’ve researched complex multigenic disease, reproductive genetics, preimplantation genetic diagnosis, and gene editing.
